Scientists Find Cas9 Enzyme That Targets HCV in Human Cells | GenomeWeb

NEW YORK (GenomeWeb) – Scientists this week described a new mechanism by which Cas9 proteins can target viral RNA.

In a paper published in the Proceedings of the National Academy of Sciences, the researchers from Emory University detailed the use of a Cas9 variant from the gram-negative bacterium Francisella novicida that can inhibit viral protein production from hepatitis C virus (HCV) RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.